Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

134.38 +0.71 (+0.53%)
Official Closing Price Updated: 7:00 PM EDT, Jun 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Got $500? 2 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Topics Artificial Intelligence
How Is The Market Feeling About Abbott Laboratories?
Via Benzinga
44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy
The 2025 TIME 100 Most Influential Companies list includes over 40 companies that investors can buy stock in. 
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
Thursday's session: top gainers and losers in the S&P500 index
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
These S&P500 stocks are gapping in today's session
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session. 
Via Chartmill
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them. 
Via The Motley Fool
Abbott, Dexcom Draw Retail Buzz As RFK Jr. Urges Americans To Embrace Health Wearables
Retail sentiment surged on Stocktwits, with message volume jumping 1,600% for Abbott and 750% for Dexcom. 
Via Stocktwits
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?
Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 17.8% and now trades at $133.43. This performance may have investors... 
Via StockStory
Topics Stocks Supply Chain
ABBOTT LABORATORIES (NYSE:ABT) – A Quality Stock Worth Considering
ABBOTT LABORATORIES (NYSE:ABT) meets key quality investing criteria with strong revenue growth, high ROIC, and solid financial health, making it a stock worth considering for long-term portfolios. 
Via Chartmill
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Steady growth and dividend increases over decades can make investors remarkably wealthy. 
Via The Motley Fool
Topics Economy
Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued
The agreement is to develop and commercialize integrated diabetes solutions that combine Abbott's future dual glucose-ketone sensor with San Diego, California- based Tandem's innovative insulin... 
Via Stocktwits
3 Low-Volatility Stocks in Hot Water
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
1 Mooning Stock with Exciting Potential and 2 to Think Twice About
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions. 
Via StockStory
ABBOTT LABORATORIES (NYSE:ABT) - A Strong Technical Setup for Breakout Investors
ABBOTT LABORATORIES (NYSE:ABT) shows strong technicals and a high-quality setup, making it a potential breakout candidate for traders. 
Via Chartmill
3 Stocks With 3% to 9% Yields Just Raised Dividends Again
Via MarketBeat
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral. 
Via Benzinga
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott
The company said the regulatory path forward for one of its key systems is too murky to pursue. 
Via Investor's Business Daily
2 Dividend Stocks to Buy With $500 and Hold Forever
Via The Motley Fool
ABBOTT LABORATORIES (NYSE:ABT) – A Quality Stock Worth Considering
ABBOTT LABORATORIES (NYSE:ABT) meets key quality investing criteria with strong revenue growth, high ROIC, and excellent profit quality, making it a solid long-term candidate. 
Via Chartmill
3 Magnificent Stocks That Are Passive Income Machines
Via The Motley Fool
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)
Via Get News
Topics Death Economy
Recent Filing Shows That Rep. Bruce Westerman Sold Over $137K Worth of Apple Stock
Via Benzinga
ABBOTT LABORATORIES (NYSE:ABT) - A Strong Technical Setup for Breakout Investors
ABBOTT LABORATORIES (NYSE:ABT) shows strong technicals and a high-quality breakout setup, supported by institutional interest and clear support/resistance levels. 
Via Chartmill
Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Abbott Laboratories (NYSE:ABT)
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Abbott Laboratories... 
Via StockStory
1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar
"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their... 
Via StockStory
Jensen Huang, Magic Johnson, Patrick Dempsey, Linda Yaccarino And More Bigwigs Headline Milken Global Conference 2025: What You Need To Know
The Milken Institute's 28th annual Global Conference, featuring prominent figures like Jensen Huang, Magic Johnson, and Linda Yaccarino, is focusing on key global issues such as AI, healthcare, and... 
Via Benzinga
Topics Artificial Intelligence
Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now
Via The Motley Fool
Topics Government Stocks World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.